Complete Story


Key Compliance Updates for Medical Associations

Pre-COVID regulatory framework did not consider virtual communication channels

Now that the world of healthcare meetings has begun returning to live meetings, medical associations/societies may be curious to find out about any recent updates to the Pharma and MedTech compliance codes, regulations and laws that might affect industry’s behavior and decision making in the run up to- and during medical congresses.  

In general, before and during the first year of the COVID pandemic, a lot of the regulatory framework did not consider virtual channels of communication with HCPs. Now most European country codes or regulations have been updated (with varying details) to reflect the interactions with HCPs through digital channels or to at least acknowledge those. And this is as it should be, as virtual meetings are here to stay and are now intertwined with the live ones in what has become known as hybrid.

Let us start with the Joint Guidance on Virtual and Hybrid International Medical Congresses by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Please select this link to read the complete article from Boardroom.

Printer-Friendly Version